MX336100B - Emulsion de ciclosporina. - Google Patents

Emulsion de ciclosporina.

Info

Publication number
MX336100B
MX336100B MX2013003578A MX2013003578A MX336100B MX 336100 B MX336100 B MX 336100B MX 2013003578 A MX2013003578 A MX 2013003578A MX 2013003578 A MX2013003578 A MX 2013003578A MX 336100 B MX336100 B MX 336100B
Authority
MX
Mexico
Prior art keywords
cyclosporine
chain triglyceride
cyclosporine emulsion
oil
phosphatidylcholine
Prior art date
Application number
MX2013003578A
Other languages
English (en)
Other versions
MX2013003578A (es
Inventor
Eskil Elmér
Original Assignee
Neurovive Pharmaceutical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43733181&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX336100(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Neurovive Pharmaceutical Ab filed Critical Neurovive Pharmaceutical Ab
Publication of MX2013003578A publication Critical patent/MX2013003578A/es
Publication of MX336100B publication Critical patent/MX336100B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

La presente invención se refiere a una emulsión de ciclosporina que contiene: i) una ciclosporina; ii) un aceite natural (triglicérido de cadena larga); iii) una fosfatidilcolina; iv) glicerol; y) una sal alcalina farmacéuticamente tolerable de un ácido graso libre, vi) un aceite de triglicérido de cadena media; vii) opcionalmente, ácido clorhídrico o hidróxido de sodio para ajustar el pH; viii) agua.
MX2013003578A 2010-10-01 2011-09-30 Emulsion de ciclosporina. MX336100B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38863310P 2010-10-01 2010-10-01
DKPA201000891 2010-10-01
PCT/EP2011/067117 WO2012042023A2 (en) 2010-10-01 2011-09-30 Cyclosporine emulsion

Publications (2)

Publication Number Publication Date
MX2013003578A MX2013003578A (es) 2013-10-25
MX336100B true MX336100B (es) 2016-01-08

Family

ID=43733181

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015002505A MX340897B (es) 2007-10-02 2010-03-30 Dispositivos modulares de punto de cuidado y usos de los mismos.
MX2013003578A MX336100B (es) 2010-10-01 2011-09-30 Emulsion de ciclosporina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015002505A MX340897B (es) 2007-10-02 2010-03-30 Dispositivos modulares de punto de cuidado y usos de los mismos.

Country Status (15)

Country Link
US (2) US9040487B2 (es)
EP (1) EP2621469B1 (es)
JP (1) JP5860468B2 (es)
KR (1) KR101801430B1 (es)
CN (2) CN104548064A (es)
AU (1) AU2011310111C9 (es)
CA (1) CA2812901C (es)
CL (1) CL2013000865A1 (es)
EA (1) EA027081B1 (es)
ES (1) ES2597959T3 (es)
HK (1) HK1208357A1 (es)
IL (1) IL225300A (es)
MX (2) MX340897B (es)
PL (1) PL2621469T3 (es)
WO (1) WO2012042023A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103443615A (zh) * 2011-03-23 2013-12-11 泰尔茂株式会社 成分测定装置
WO2013082458A1 (en) 2011-12-02 2013-06-06 The Regents Of The University Of California Reperfusion protection solution and uses thereof
KR101211902B1 (ko) * 2012-04-30 2012-12-13 주식회사 휴온스 사이클로스포린 함유 무자극성 나노에멀젼 안약 조성물
JP2017506671A (ja) * 2014-02-14 2017-03-09 ホアン，ジンジュン ナノエマルジョン送達系の組成物
CN104055749B (zh) * 2014-05-27 2017-05-24 无锡曙辉药业有限公司 环孢素a的自微乳化软胶囊内容物组合及其制备方法
CN105267144B (zh) * 2014-07-04 2020-08-18 四川科伦药业股份有限公司 一种环孢素脂肪乳注射液
WO2017147470A1 (en) * 2016-02-26 2017-08-31 The Regents Of The University Of California Bicontinuous microemulsions and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0361928B1 (en) * 1988-09-29 1994-04-27 Shiseido Company Limited Emulsified composition
US5527537A (en) * 1992-05-18 1996-06-18 Dietl; Hans Pharmaceutical preparation containing cyclosporine(s) for intravenous administration and a process for its production
JP3200639B2 (ja) 1992-05-19 2001-08-20 カシオ計算機株式会社 薄膜トランジスタパネルの製造方法
US5660858A (en) 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
DE19961733A1 (de) 1999-12-21 2001-06-28 Ciclomulsion Ag Cyclosporin(e) enthaltende hypertone pharmazeutische Zubereitung zur Anwendung bei neurologischen Erkrankungen und als Neuroprotektivum sowie Verfahren zu ihrer Herstellung
EP1929996B1 (en) 2004-11-09 2011-02-16 Novagali Pharma S.A. Ophthalmic emulsions containing an immunosuppressive agent
CN101904814A (zh) * 2009-06-04 2010-12-08 上海恒瑞医药有限公司 制备载药乳剂的方法

Also Published As

Publication number Publication date
US20130323270A1 (en) 2013-12-05
AU2011310111C1 (en) 2015-05-07
KR101801430B1 (ko) 2017-11-24
EA027081B1 (ru) 2017-06-30
US9040487B2 (en) 2015-05-26
IL225300A0 (en) 2013-06-27
CN104548064A (zh) 2015-04-29
EP2621469B1 (en) 2016-07-20
JP5860468B2 (ja) 2016-02-16
AU2011310111B2 (en) 2014-08-14
MX2013003578A (es) 2013-10-25
CN103118664B (zh) 2015-11-25
WO2012042023A3 (en) 2012-06-21
EA201390507A1 (ru) 2013-08-30
US20150238563A1 (en) 2015-08-27
CA2812901C (en) 2019-02-19
AU2011310111B9 (en) 2016-11-24
WO2012042023A2 (en) 2012-04-05
AU2011310111A1 (en) 2013-04-04
EP2621469A2 (en) 2013-08-07
AU2011310111C9 (en) 2016-11-24
CA2812901A1 (en) 2012-04-05
CL2013000865A1 (es) 2014-03-28
PL2621469T3 (pl) 2017-01-31
MX340897B (es) 2016-07-29
JP2013538843A (ja) 2013-10-17
ES2597959T3 (es) 2017-01-24
IL225300A (en) 2017-06-29
KR20130124944A (ko) 2013-11-15
HK1208357A1 (en) 2016-03-04
CN103118664A (zh) 2013-05-22

Similar Documents

Publication Publication Date Title
MX336100B (es) Emulsion de ciclosporina.
MY183602A (en) Synthesis of fucosylated compounds
EA201200751A8 (ru) Солевая форма конъюгата многолучевого полимера - лекарственного средства
MX2019004378A (es) Edulcorante de estevia altamente soluble.
NZ703162A (en) Heterocyclic modulators of lipid synthesis
UA114717C2 (uk) Протиобліднювальна композиція
HK1171245A1 (en) Alcoholic compositions having a lowered risk of acetaldehydemia
GEP20125708B (en) Hydroxamate-based inhibitors of deacetylases b
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
MX348831B (es) Administración parenteral de tapentadol.
WO2010096123A3 (en) Amino acid salts of prostaglandins
CR20120261A (es) Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica
UA101091C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
SG155153A1 (en) Process for the preparation of polycarbonate
IN2012DN05209A (es)
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
MX2011009898A (es) Proceso para la obtencion de derivados de acido propionico.
EA201790616A2 (ru) Способ и реагенты для ингибирования или уменьшения образования отложений на стенках трубопроводов во время получения фосфорной кислоты
AR074545A1 (es) Proceso de preparacion de dihidroetorfina
CY1118413T1 (el) Κρυσταλλικη μορφη πεμιρολαστης
BR112012017991A2 (pt) produto de higiene oral para cuidado de esmalte sensível.
UA106386C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
CR20110385A (es) Composiciones y metodo para bloquear la respuesta de etileno en cultivos usando sal sodica de 3- (ciclopropil-1-enil)- propanoico
WO2012150607A3 (en) Oral liquid composition comprising divalproex sodium and process for preparing thereof
WO2011058521A3 (en) Process for the preparation of crystalline form i of l-malic acid salt of sunitinib